Analysis of Clinical Trials of New Drugs for Liver Diseases in China
Longfei Lin, Hui Li Institute Chinese materia medica china academy of Chinese medical sciences, Beijing, People’s Republic of ChinaCorrespondence: Hui LiInstitute Chinese materia medica china academy of Chinese medical sciences, Dongcheng District Dongzhimen Nanxiaojie Within 16, Beijing, People’s R...
Main Authors: | Lin L, Li H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/analysis-of-clinical-trials-of-new-drugs-for-liver-diseases-in-china-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Liver disease referrals to an urban, hospital‐based hepatology outpatient clinic over the past 25 years
by: Micah Grubert Van Iderstine, et al.
Published: (2020-06-01) -
Liver Fibrosis: A Clinical Update
by: Lindsey C. Shipley, et al.
Published: (2019-05-01) -
Effect of pregnancy on pre-existing liver disease: Chronic viral hepatitis
by: Silvia Sookoian
Published: (2006-07-01) -
Liver disease during pregnancy: acute viral hepatitis
by: Silvia Sookoian
Published: (2006-07-01) -
Trends of liver cancer and its major risk factors in Korea
by: Eun-young Lee, et al.
Published: (2015-03-01)